JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Intuitive Surgical Inc

Gesloten

SectorGezondheidszorg

471.65 0.36

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

468.33

Max

475.46

Belangrijke statistieken

By Trading Economics

Inkomsten

-45M

658M

Verkoop

187M

2.4B

K/W

Sectorgemiddelde

67.603

34.393

EPS

1.81

Winstmarge

26.984

Werknemers

15,638

EBITDA

268M

987M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+28.25% upside

Dividenden

By Dow Jones

Volgende Winsten

16 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-12B

173B

Vorige openingsprijs

471.29

Vorige sluitingsprijs

471.65

Nieuwssentiment

By Acuity

10%

90%

5 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bearish Evidence

Intuitive Surgical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 jul 2025, 21:13 UTC

Winsten

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 apr 2025, 20:55 UTC

Winsten

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23 jan 2025, 21:41 UTC

Winsten

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 jan 2025, 18:37 UTC

Acquisities, Fusies, Overnames

Intuitive to Establish Direct Presence in Europe With Acquisition

22 jul 2025, 20:14 UTC

Winsten

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 jul 2025, 20:13 UTC

Winsten

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 jul 2025, 20:13 UTC

Winsten

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q Net $658.4M >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 apr 2025, 20:13 UTC

Winsten

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Net $698.4M >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 jan 2025, 21:17 UTC

Winsten

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 jan 2025, 18:18 UTC

Winsten

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 jan 2025, 13:11 UTC

Top Nieuws

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 jan 2025, 09:51 UTC

Populaire aandelen

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 jan 2025, 21:10 UTC

Winsten

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 jan 2025, 21:09 UTC

Winsten

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 jan 2025, 21:09 UTC

Winsten

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q Net $685.7M >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q EPS $1.88 >ISRG

Peer Vergelijking

Prijswijziging

Intuitive Surgical Inc Prognose

Koersdoel

By TipRanks

28.25% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 602.89 USD  28.25%

Hoogste 685 USD

Laagste 440 USD

Gebaseerd op 22 Wall Street-analisten die 12-maands prijsdoelen bieden voor Intuitive Surgical Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

22 ratings

17

Buy

4

Hold

1

Sell

Technische score

By Trading Central

514.59 / 539.05Steun & Weerstand

Korte Termijn

Weak Bearish Evidence

Gemiddeld Termijn

Weak Bullish Evidence

Lange Termijn

Strong Bullish Evidence

Sentiment

By Acuity

5 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.